M&A Deal Summary

ANI Pharmaceuticals Acquires ANI Pharmaceuticals

On October 4, 2012, ANI Pharmaceuticals acquired life science company ANI Pharmaceuticals

Acquisition Highlights
  • This is ANI Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is ANI Pharmaceuticals’ 2nd transaction in the United States.
  • This is ANI Pharmaceuticals’ 2nd transaction in Minnesota.

M&A Deal Summary
Date 2012-10-04
Target ANI Pharmaceuticals
Sector Life Science
Buyer(s) ANI Pharmaceuticals
Deal Type Merger
Advisor(s) SNR Denton LLP (Legal)

Target

ANI Pharmaceuticals

Baudette, Minnesota, United States
ANI Pharmaceuticals, Inc. is a manufacturer of over-the-counter products. ANI focuses on liquid dosage forms, such as clear solutions and suspensions. ANI plans to develop Rx products internally and to acquire products and/or companies within the area. ANI Pharmaceuticals was established in 1996 and is based in Baudette, Minnesota.

Search 192,297 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ANI Pharmaceuticals

Baudette, Minnesota, United States

website

Category Company
Founded 2001
Sector Life Science
Employees369
Revenue 208M USD (2020)
DESCRIPTION

ANI Pharmaceuticals is a developer, manufacturer, and marketer of top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI has several ANDAs pending FDA approval and in various stages of development. ANI Pharmaceuticals was formed in 2001 and is based in Baudette, Minnesota.

DEAL STATS #
Overall 2 of 14
Sector (Life Science) 2 of 12
Type (Merger) 1 of 1
State (Minnesota) 2 of 2
Country (United States) 2 of 11
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-05-07 Solvay Pharmaceuticals - Rx Facilities

Baudette, Minnesota, United States

Solvay Pharmaceuticals - Rx Facilities plants add 173,000 sq. ft. of manufacturing and laboratory capacity, substantially expanding capabilities and enhancing its already-rapid growth.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-26 Teva Pharmaceutical - 31 Generic Drug Products

United States

Teva Pharmaceutical - 31 Generic Drug Products includes 20 solid-oral immediate release products, 4 extended release products and 7 liquid products.

Buy $13M
Mergr

Product

Company

Legal